| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/22/2003 | EP1276762A1 Porphyromonas gingivalis recombinant proteins and truncations |
| 01/22/2003 | EP1276761A2 New bromodomain protein |
| 01/22/2003 | EP1276755A1 Novel compounds |
| 01/22/2003 | EP1276750A1 Antisense modulation of zinc finger protein-217 expression |
| 01/22/2003 | EP1276702A2 Compositions and methods for detecting and quantifying gene expression |
| 01/22/2003 | EP1276508A2 A particulate complex for administering nucleic acid into a cell |
| 01/22/2003 | EP1276500A1 Blocking leukocyte emigration and inflammation by interfering with cd99/hec2 |
| 01/22/2003 | EP1276494A1 A memory enhancing protein |
| 01/22/2003 | EP1276371A2 Transgenic animal |
| 01/22/2003 | EP1222459A4 Crystallographic structure of the androgen receptor ligand binding domain |
| 01/22/2003 | EP1151138A4 Use of fluorescent molecular beacons in the detection of methylated nucleic acids |
| 01/22/2003 | EP0973901B1 Flip gene and flip protein |
| 01/22/2003 | EP0963207A4 Il-12 gene therapy of tumors |
| 01/22/2003 | EP0954607A4 Genetic alterations associated with prostate cancer |
| 01/22/2003 | EP0880312A4 Plants having mutant sequences that confer altered fatty acid profiles |
| 01/22/2003 | EP0853679B1 Expression monitoring by hybridization to high density oligonucleotide arrays |
| 01/22/2003 | EP0832199A4 Fucosyltransferase genes and uses thereof |
| 01/22/2003 | EP0653067B1 Method and kit for pyridinium crosslink assay |
| 01/22/2003 | EP0627004B1 Improvements in or relating to malaria vaccine |
| 01/22/2003 | EP0610436B1 Hepatitis-c virus testing |
| 01/22/2003 | EP0540651B1 Endogenously sweetened transgenic plant products |
| 01/22/2003 | CN1393020A Electromagnetic device and high-voltage geratating device and method of producing electromagnetic device |
| 01/22/2003 | CN1392798A Mimetic peptides for epitope of apolipoprotein B-100, concatemer and modified peptides, and vaccine composition comprising same |
| 01/22/2003 | CN1392797A High mannose proteins and method of making mannose proteins |
| 01/22/2003 | CN1392772A Animal showing schizophrenia-like abnormality in coagnitive behaviors and method of construction same |
| 01/22/2003 | CN1392727A Device and method for reproducing data from storage medium containing preloading character |
| 01/22/2003 | CN1392261A Glyphosate degrading enzyme gene and carrier containing said gene |
| 01/22/2003 | CN1392260A Method for deleting specific foreign gene using two recombination systems |
| 01/22/2003 | CN1392259A CR1 gene ralative to cell reconstitution, conduction and death |
| 01/22/2003 | CN1392153A Process for prparing cytidine compound |
| 01/22/2003 | CN1099462C Medical composition |
| 01/22/2003 | CN1099423C Human neuropeptide receptor |
| 01/21/2003 | US6509516 Male-sterile brassica plants and methods for producing same |
| 01/21/2003 | US6509515 Transgenic mice expressing mutant human APP and forming congo red staining plaques |
| 01/21/2003 | US6509514 Chimeric animal model susceptible to human hepatitis C virus infection |
| 01/21/2003 | US6509460 Nucleoside triphosphates and their incorporation into oligonucleotides |
| 01/21/2003 | US6509458 Gene expressed in prostate cancer |
| 01/21/2003 | US6509456 Polynucleotide coding protease protein |
| 01/21/2003 | US6509455 Recombinant narbonolide polyketide synthase |
| 01/21/2003 | US6509454 Free solution ligand interaction molecular separation method |
| 01/21/2003 | US6509452 Solubilizing the recombinant bacteria with a surfactant or permeabilizing agent which separates native cell proteins from cell membrane without separating the recombinant protein from the cell, wherein the inclusion bodies remain intact |
| 01/21/2003 | US6509450 Immunoassay for quantification of C-terminal telopeptides of type I collagen in human serum |
| 01/21/2003 | US6509449 To provide a detection method for assaying the polypeptide using the monoclonal antibody |
| 01/21/2003 | US6509447 G protein chimeras and methods of screening compounds |
| 01/21/2003 | US6509446 Recombinant genetic information (DNA or RNA), consisting a Chicken Anemia Virus (CAV)-specific nucleotide sequence, useful for diagonestics, vaccination or protein production |
| 01/21/2003 | US6509445 Effective metastasis inhibitory actions based on combined properties of two proteins; cancerous metastasis inhibitor with lower toxicity |
| 01/21/2003 | US6509443 Amino acid residue located at position 63 of native-sequence human Insulin like Growth Factor-I is replaced with an alanine residue or amino acid residues at positions 1 and 70 are replaced with serine and valine respectively |
| 01/21/2003 | US6509442 Novel mutations which are associated with aberrant iron metabolism, absorption, or storage, or in advanced cases, clinical hemochromatosis |
| 01/21/2003 | US6509307 Detergent compositions comprising phenol oxidizing enzymes from fungi |
| 01/21/2003 | US6509191 Nucleotide sequences coding plant polypeptide; for use in the generation of transgenic plants of preferential phenotypes |
| 01/21/2003 | US6509190 DNA regulatory element for the expression of transgenes in neurons of the mouse forebrain |
| 01/21/2003 | US6509185 Provides for a 100-fold increase in the production of a protein from Bacillus subtilis |
| 01/21/2003 | US6509183 Preparing alkaline pullulanase which comprises culturing a transformed microorganism which has been transformed with a recombinant vector containing a DNA fragment coding for alkaline pullulanase |
| 01/21/2003 | US6509175 Generating preferential nucleotide sequences; obtain nucleotide sequences, incubate with primers, amplify, recover nucleotide sequences |
| 01/21/2003 | US6509174 Cells, genetically modified with optical marker |
| 01/21/2003 | US6509173 Related members of a broad class of polypeptide mediators, which includes the interferons, interleukins and growth factors, collectively called cytokines |
| 01/21/2003 | US6509171 Aspartic proteinase deficient filamentous fungi |
| 01/21/2003 | US6509159 Methods related to Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins |
| 01/21/2003 | US6509156 Efficient homologous recombination mechanism between two DNA molecules occurs at usable frequencies in a bacterial host cell which is capable of expressing the products of the recE and recT genes or functionally related genes |
| 01/21/2003 | US6509155 Characterization, diagnosis, prevention, and treatment of cell signaling, immune, and cell proliferative disorders, particularly colon cancer |
| 01/21/2003 | US6509153 Genetic markers of toxicity preparation and uses |
| 01/21/2003 | US6509152 Immunosuppressant target proteins |
| 01/21/2003 | US6509151 DNA molecule encoding a Mycobacterium protein and conferring on Mycobacterium tuberculosis an ability to enter mammalian cells and to survive within macrophages |
| 01/21/2003 | US6509150 Producing rAAV with very high yields of infectious particles and essentially free of detectable adenovirus contamination |
| 01/21/2003 | US6509149 HPV-specific oligonucleotides |
| 01/21/2003 | US6509032 Nontoxic biodegradable derivative of cholesterol having carbamate, ester or amide linker, spacer and primary, tertiary or quaternized amino groups; transfection of nucleic acids into cells |
| 01/21/2003 | US6509026 Osteopontin coated surfaces and methods of use |
| 01/21/2003 | US6509021 Use of mutated subtilisin protease in cosmetic products |
| 01/21/2003 | US6509020 Replication-competent herpes simplex virus |
| 01/21/2003 | US6509019 Immunologically active proteins from Borrelia burgdorferi |
| 01/21/2003 | US6509018 Expressed peptides, in particular a strain designated YBF30; including V3 loop region and corresponding nucleotide sequences |
| 01/21/2003 | US6509017 Vaccines containing nucleic acid fragments encoding antigenic proteins that increase resistance to infection; isolated, purified polypeptide having amino acid sequence 1-598 of seq id no: 6 or 1-600 of seq id no: 8 |
| 01/21/2003 | US6509016 Delaying recurrence of ganglioside 2 associated tumors; antibody comprising the light and heavy chain variable region sequences contained in seq id no: 2 and 4 |
| 01/21/2003 | US6509015 Human antibodies that bind human TNFa |
| 01/21/2003 | US6508714 Split spool type flexible coupling |
| 01/21/2003 | CA2453344A1 Novel nucleic acids and secreted polypeptides |
| 01/21/2003 | CA2306053C Mobilization of viral genomes from t-dna using site-specific recombination systems |
| 01/21/2003 | CA2256686C Multicomponent analysis method including the determination of a statistical confidence interval |
| 01/21/2003 | CA2234071C Intensive homologous promoter obtained from hamsters |
| 01/21/2003 | CA2204253C Methods and devices for immunizing a host through administration of naked polynucleotides which encode antigenic peptides |
| 01/21/2003 | CA2187624C Method of eliminating genetic routes for bacteriophage evolution and products produced thereby |
| 01/21/2003 | CA2130784C Plasmid derived from lactobacillus delbrueckii sp. |
| 01/21/2003 | CA2100159C Rapid assays for amplification products |
| 01/21/2003 | CA2096529C Recombinant avirulent salmonella antifertility vaccines |
| 01/21/2003 | CA2063592C Process for preparing a protein by a fungus transformed by multicopy integration of an expression vector |
| 01/21/2003 | CA1341417C Hirudine-expressing vectors, altered cells, and a process for hirudine preparation |
| 01/21/2003 | CA1341416C Hirudine variants, their use and preparation process |
| 01/18/2003 | CA2352702A1 Novel human proton gated ion channel |
| 01/17/2003 | CA2407295A1 Transgenic non-human mammal |
| 01/17/2003 | CA2352439A1 Engineering oncolytic viruses |
| 01/16/2003 | WO2003005036A2 Epf receptor assays, compounds and therapeutic compositions |
| 01/16/2003 | WO2003004992A2 Mammalian sweet and amino acid heterodimeric taste receptors |
| 01/16/2003 | WO2003004705A1 Phosphorothioate antisense heparanase oligonucleotides |
| 01/16/2003 | WO2003004704A2 Method of selecting dna sequence with transcription modulating activity using a vector comprising an element with a gene transcription repressing activity |
| 01/16/2003 | WO2003004703A1 Process for producing template dna and process for producing protein in cell-free protein synthesis system with the use of the same |
| 01/16/2003 | WO2003004701A2 Method for determining the capacity of fusarium in producing trichothecene toxins |
| 01/16/2003 | WO2003004700A1 Method and system for detecting inter-chromosomal imbalance by fluorescent in situ hybridization (fish) on interphase nuclei |
| 01/16/2003 | WO2003004699A2 Method for identifying nucleic acid molecules amplified in a polymerase chain reaction |
| 01/16/2003 | WO2003004698A2 Method for monitoring and modulating protein folding |
| 01/16/2003 | WO2003004696A2 A distributed system for epigenetic based prediction of complex phenotypes |